<< Read Full Article
<< Read Full Article
The Biotech Stock Mailbag is once again open for business.
Before I get to your emails, I want to make sure everyone has seen my recent event calendars listing upcoming FDA approvals and clinical trial results. There were two of the latter, which you can read here and here.
This is helpful information for health care investors, so clip and save. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet